Novo Integrated Sciences, Inc.
NVOS
$0.065
$0.009316.70%
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.08M | 3.15M | 3.17M | 3.89M | 3.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.08M | 3.15M | 3.17M | 3.89M | 3.30M |
| Cost of Revenue | 1.50M | 2.26M | 1.85M | 1.95M | 2.38M |
| Gross Profit | 1.58M | 896.90K | 1.32M | 1.94M | 928.20K |
| SG&A Expenses | 2.51M | 3.42M | 2.86M | 5.26M | 4.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.02M | 5.67M | 4.71M | 7.21M | 6.40M |
| Operating Income | -936.30K | -2.52M | -1.54M | -3.32M | -3.09M |
| Income Before Tax | 5.01M | -13.74M | -2.75M | -4.66M | -3.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.01M | -13.74M | -2.75M | -4.66M | -3.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.40K | -5.60K | -600.00 | -19.60K | 41.80K |
| Net Income | 5.00M | -13.74M | -2.75M | -4.68M | -3.16M |
| EBIT | -936.30K | -2.52M | -1.54M | -3.32M | -3.09M |
| EBITDA | -372.10K | -1.96M | -971.60K | -2.75M | -2.51M |
| EPS Basic | 0.26 | -0.74 | -0.16 | -0.28 | -0.21 |
| Normalized Basic EPS | 0.20 | -0.46 | -0.10 | -0.15 | -0.13 |
| EPS Diluted | 0.26 | -0.74 | -0.16 | -0.28 | -0.21 |
| Normalized Diluted EPS | 0.20 | -0.46 | -0.10 | -0.15 | -0.13 |
| Average Basic Shares Outstanding | 19.06M | 18.69M | 17.64M | 16.73M | 14.91M |
| Average Diluted Shares Outstanding | 19.06M | 18.69M | 17.64M | 16.73M | 14.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
